Overview
Michael Jebaraj practices in Ulm, Germany. Jebaraj is highly rated in 4 conditions, according to our data. Their top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, and Small Lymphocytic Lymphoma (SLL).
Their clinical research consists of co-authoring 20 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic B-Cell Leukemia (CBCL)Jebaraj isDistinguished. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Jebaraj isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Advanced
- LeukemiaJebaraj isAdvanced. Learn about Leukemia.
- Small Lymphocytic Lymphoma (SLL)
- Experienced
- EpendymomaJebaraj isExperienced. Learn about Ependymoma.
- Mantle Cell Lymphoma (MCL)Jebaraj isExperienced. Learn about Mantle Cell Lymphoma (MCL).
- Non-Hodgkin LymphomaJebaraj isExperienced. Learn about Non-Hodgkin Lymphoma.